Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
Taylor M. Patek
Chengwen Teng
Kaitlin E. Kennedy
Carlos A. Alvarez
Christopher R. Frei
机构：
[1] The University of Texas at Austin,Pharmacotherapy Division, College of Pharmacy
[2] The University of Texas Health Science Center at San Antonio,Pharmacotherapy Education and Research Center, Long School of Medicine
[3] Texas Tech University Health Sciences Center,Division of Clinical/Translational Research, Hodge School of Pharmacy
[4] South Texas Veterans Health Care System,undefined
[5] University Health System,undefined
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication of the article, the second sentence in the figure 2 caption should read as below:
引用
收藏
页码：825 / 825
相关论文
共 50 条
  • [1] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Patek, Taylor M.
    Teng, Chengwen
    Kennedy, Kaitlin E.
    Alvarez, Carlos A.
    Frei, Christopher R.
    DRUG SAFETY, 2020, 43 (01) : 17 - 22
  • [2] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Taylor M. Patek
    Chengwen Teng
    Kaitlin E. Kennedy
    Carlos A. Alvarez
    Christopher R. Frei
    Drug Safety, 2020, 43 : 17 - 22
  • [3] Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS) (vol 43, pg 17, 2020)
    Patek, Taylor M.
    Teng, Chengwen
    Kennedy, Kaitlin E.
    Alvarez, Carlos A.
    Frei, Christopher R.
    DRUG SAFETY, 2020, 43 (08) : 825 - 825
  • [4] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    Drugs - Real World Outcomes, 2022, 9 : 23 - 29
  • [5] Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Baus, Courtney
    Wilson, James P.
    Frei, Christopher R.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (11): : 1504 - 1509
  • [6] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
  • [7] A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
    He, Luyao
    Shen, Mengting
    Zhang, Lei
    Li, Yan
    Li, Huafang
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [8] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [9] Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Kong, Wenqiang
    Shu, Yunfeng
    Tang, Juan
    Wan, Jie
    Yang, Xueting
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [10] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine
    Zhang, Cheng
    Li, Ke
    Xu, Shu-Ning
    Qiao, Lei
    Ren, Yu-Lin
    Li, Qun
    Liu, Ying
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 365 - 376
12345